R A Silva1, D M Moshfeghi1. Show Affiliations » 1. Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
Abstract
Entities: Disease
Mesh: See more » Antibodies, Antiphospholipid/bloodAntibodies, Monoclonal, Humanized/therapeutic useAntiphospholipid Syndrome/bloodAntiphospholipid Syndrome/diagnosisAntiphospholipid Syndrome/drug therapyChoroid Diseases/bloodChoroid Diseases/diagnosisChoroid Diseases/drug therapyComplement Inactivating Agents/therapeutic useElectroretinographyHumansMaleMiddle AgedTomography, Optical CoherenceVision Disorders/diagnosisVisual Acuity
Substances: See more » Antibodies, AntiphospholipidAntibodies, Monoclonal, HumanizedComplement Inactivating Agentseculizumab
Year: 2014 PMID: 24603416 PMCID: PMC4058606 DOI: 10.1038/eye.2014.39
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 3.775